OVERVIEW

Now in its 20th year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include the role for vitamin D in bone health, and racial differences and disparities in osteoporosis care.

TARGET AUDIENCE

The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

LEARNING OBJECTIVES

• Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
• Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
• Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
• Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
• Understand the evidence for vitamin D in the optimization of bone health;
• Recognize racial differences and disparities in osteoporosis care

ACCREDITATION

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

For more information please visit the official event page.